Bernard A, Hermans C
Unit of Industrial Toxicology and Occupational Medicine, Faculty of Medicine, Catholic University of Louvain, Brussels, Belgium.
Sci Total Environ. 1997 Jun 20;199(1-2):205-11. doi: 10.1016/s0048-9697(97)05497-1.
Biomarkers of toxicity are usually altered before the onset of functional changes or clinical manifestations. Peripheral biomarkers of toxicity present an additional advantage in that they can be applied on easily accessible biological materials (blood or urine). They represent useful tools that can be used for identifying subjects or groups at risk in the industry or environment, or for establishing acceptable exposure levels. In the case of the kidney, for instance, a relatively large battery of peripheral markers has been developed during the last decade. These markers are either constituents of the renal parenchyma whose urinary excretion can signal lesions or an abnormal secretion, or plasma proteins reflecting the integrity of nephron structures involved in their selective filtration or reabsorption. The epidemiological application of these tests has revealed that widespread occupational or environmental pollutants such as lead, cadmium, crystalline silica or perchloroethylene may cause very early effects on different segments of the nephron. In the case of the lung, we have recently identified a lung toxicity biomarker applicable not only on bronchoalveolar lavage fluid but also or sputum provided some precautions are taken. This biomarker called Clara cell protein (CC16) is a kDa protein secreted in the respiratory tract by the non-ciliated Clara cells known for their vulnerability to toxic insult. Studies on occupationally exposed workers and experimental animals indicate that the assay of CC16 in serum is a sensitive and a relatively specific test to detect early acute or chronic effects of toxicants on the tracheobronchial tree. The ultimate goal, however, is the development and validation of biomarkers that have a sufficient toxicological relevance to be used for health risk assessment. It is thus of premier importance to establish in health significance of early biomarkers of toxicity by determining to what extent they reflect critical steps in, and are predictive of the development of a chronic and irreversible disease.
毒性生物标志物通常在功能变化或临床表现出现之前就已发生改变。毒性外周生物标志物具有额外的优势,因为它们可以应用于易于获取的生物材料(血液或尿液)。它们是有用的工具,可用于识别工业或环境中的高危个体或群体,或用于确定可接受的暴露水平。例如,在肾脏方面,过去十年间已开发出一系列相对丰富的外周标志物。这些标志物要么是肾实质的成分,其尿液排泄可表明损伤或异常分泌,要么是反映参与其选择性滤过或重吸收的肾单位结构完整性的血浆蛋白。这些检测的流行病学应用表明,铅、镉、结晶硅或全氯乙烯等广泛存在的职业或环境污染物可能对肾单位的不同节段产生非常早期的影响。在肺部方面,我们最近发现了一种肺毒性生物标志物,不仅适用于支气管肺泡灌洗液,在采取一些预防措施的情况下也适用于痰液。这种名为克拉拉细胞蛋白(CC16)的生物标志物是一种由无纤毛的克拉拉细胞分泌到呼吸道中的千道尔顿蛋白,这些细胞因其易受毒性损伤而闻名。对职业暴露工人和实验动物的研究表明,检测血清中的CC16是检测毒物对气管支气管树早期急性或慢性影响的一种敏感且相对特异的检测方法。然而,最终目标是开发和验证具有足够毒理学相关性以用于健康风险评估的生物标志物。因此,通过确定早期毒性生物标志物在多大程度上反映慢性不可逆疾病发展的关键步骤并对其进行预测,来确立其健康意义至关重要。